blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics is the only software platform tailored to running precision medicine clinical trials, leveraging AI to manage all aspects from design to patient r...
Continue reading

Strategic data sharing in precision medicine: A checklist for biotech and pharma

In the ever-changing field of precision medicine, continuous evaluation of data sharing and collaboration practices is essential for biotech and pharma companie...
Continue reading

Genomic literacy and health disparities in genetic research

Genetics now shapes how medicines are developed, how patients are diagnosed, and how clinical decisions are made. Yet a persistent gap exists between the pace o...
Continue reading

Cultural competence in genomic medicine

Genetic variation across populations has direct consequences for precision medicine trial design. As patient populations in clinical research become more ethnic...
Continue reading

Towards inclusive health: Bridging genomic data and equity in healthcare

Health equity, defined as everyone having the opportunity to be as healthy as possible, has long been a primary goal of public health. Still, across the world, ...
Continue reading

Inclusive genomics: Unlocking equitable healthcare through diversity

Our new whitepaper "Inclusive genomics: A path to equitable precision medicine" offers a close look at the intersection of genomic research and diversity. It's ...
Continue reading

Introducing Light the Way [press release]

Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Genetics launches ‘Ligh...
Continue reading

COVID-19 and genomic sequencing: Tracking variants and lessons for future pandemics

As COVID-19 continues to affect us all, it has become evident that our fight against the virus is not just about developing vaccines and therapeutics. Equally c...
Continue reading

The long haul: How long COVID continues to challenge healthcare

Long COVID, affecting nearly 28% of COVID-19 survivors, is a multifaceted condition that extends well beyond its initial impact. Typical include fatigue, concen...
Continue reading

Webinar recap: Ethical and regulatory landscapes in precision medicine

The rapidly evolving landscape of precision medicine has opened new avenues for personalised treatments, transforming how we approach patient care. Genetic info...
Continue reading